Highlights from ASH Annual Meeting 2024 by Naveen Pemmaraju
The 66th ASH Annual Meeting (ASH24) is taking place from December 7-10, 2024, in San Diego, California.
The American Society of Hematology (ASH) is the world’s largest professional society of clinicians and scientists who are dedicated to conquering blood diseases. Since 1958, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology.
In connection to this event, Naveen Pemmaraju shared several posts from ASH Annual Meeting and Exposition 2024:
“ASH Kudos to our faculty speakers & to all who attended & supported our ASH Education Session on Rare Myeloid Neoplasms yest featuring our talks on BPDCN, CSF3R-expressing malignancies & acute leukemia of ambiguous lineage!!”
“Rare Myeloid Neoplasm team heading into 9:30 am MPN oral session together!”
Congratulations to Dr. Hannah Goulart
“Very many congratulations & ASH Kudos to Dr. Hannah Goulart on an outstanding job presenting our group’s poster in MPNSM session on characteristics & outcomes in MPN AYA patients!”
Potential new directions of older JAKi
“Very interesting MPN oral session this AM on potential new directions of older JAKi, novel JAKi and beyond JAKi agents.”
Honored to hang out with Dr. Shematologist
“Honored to hang out with the-one-and-only Dr. Shematologist today at ASHCentral !!!!!”
“Taco lunch outing with MPNSM crew to El Chingon!”
ASH Kudos to our brilliant Internal Medicine resident
“Congratulations & ASH Kudos to our brilliant Internal Medicine resident MD Dr Ani Lankford for her outstanding poster tonight at ASH Poster Session!!”
Wonderful to meet Dr. Mohan Narla
“Wonderful to meet Dr. Mohan Narla, President ASH at ASH24 President’s Reception Bollywood theme!!!
Amazing BPDCN MPNSM leusm | Naveen Pemmaraju & Dr. Mohan Narla.”
“At ASH President’s Reception!
ASHKudos to ASH & Dr. Mohan Narla for a lovely reception!”
“Lovely to spend time with dear friends at the intersection of Multiple Myeloma & leusm with Ajai Chari, Naveen Pemmaraju, Nina Shah.”
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML. He has been named MDACC’s, Department of Leukemia, Inaugural Director of BPDCN Program, in 2020, which is one of the world’s most active BPDCN research programs. Dr. Pemmaraju is the recipient of the MDACC Gerald P. Bodey Award for Excellence in Education in 2020. He is a well-known social media influencer and advocate.
More posts from ASH24 on OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023